SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-23-090618
Filing Date
2023-11-28
Accepted
2023-11-28 17:16:15
Documents
15
Period of Report
2023-07-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K f10k2023a1_enzobio.htm   iXBRL 10-K/A 367797
2 CERTIFICATION f10k2023a1ex31-1_enzobio.htm EX-31.1 10894
3 CERTIFICATION f10k2023a1ex31-2_enzobio.htm EX-31.2 11143
  Complete submission text file 0001213900-23-090618.txt   658773

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE enz-20230731.xsd EX-101.SCH 3203
5 XBRL DEFINITION FILE enz-20230731_def.xml EX-101.DEF 16918
6 XBRL LABEL FILE enz-20230731_lab.xml EX-101.LAB 34878
7 XBRL PRESENTATION FILE enz-20230731_pre.xml EX-101.PRE 17975
9 EXTRACTED XBRL INSTANCE DOCUMENT f10k2023a1_enzobio_htm.xml XML 6456
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-K/A | Act: 34 | File No.: 001-09974 | Film No.: 231447494
SIC: 8071 Services-Medical Laboratories